Arend L. Schinkel

Rotterdam, ZH, Netherlands

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 102 publications

Differences in antihypertensive drug blood levels in patients with hypertension (DECISION): a prospective study comparing pharmacokinetics and pharmacodynamics of perindopril in younger and older patients.

Differences in antihypertensive drug blood levels in patients with hypertension (DECISION): a prospective study comparing pharmacokinetics and pharmacodynamics of perindopril in younger and older patients.

Journal: Blood pressure

Published: October 24, 2025

Decreased Aortic Elasticity in Noncompaction Cardiomyopathy Compared to Dilated Cardiomyopathy.

Decreased Aortic Elasticity in Noncompaction Cardiomyopathy Compared to Dilated Cardiomyopathy.

Journal: Journal of cardiovascular development and disease

Published: May 14, 2025

Cardiovascular magnetic resonance-derived metrics as diagnostic markers for left ventricular outflow tract obstruction in hypertrophic cardiomyopathy.

Cardiovascular magnetic resonance-derived metrics as diagnostic markers for left ventricular outflow tract obstruction in hypertrophic cardiomyopathy.

Journal: Journal of cardiovascular magnetic resonance : official journal of the Society for Cardiovascular Magnetic Resonance

Published: May 05, 2025

Accelerometry-defined physical activity and quality of life in hypertrophic cardiomyopathy.

Accelerometry-defined physical activity and quality of life in hypertrophic cardiomyopathy.

Journal: Heart (British Cardiac Society)

Published: April 04, 2025

Genotype-negative hypertrophic cardiomyopathy: Exploring the role of cardiovascular risk factors in disease expression.

Genotype-negative hypertrophic cardiomyopathy: Exploring the role of cardiovascular risk factors in disease expression.

Journal: International journal of cardiology

Published: March 18, 2025

Reply to: Family screening for hypertrophic cardiomyopathy: initial cardiologic assessment, and long-term follow-up of genotype-positive phenotype-negative individuals.

Reply to: Family screening for hypertrophic cardiomyopathy: initial cardiologic assessment, and long-term follow-up of genotype-positive phenotype-negative individuals.

Journal: International journal of cardiology

Published: February 26, 2025

Assessing the psychometric properties of generic (EQ-5D-5L) and disease-specific (KCCQ) quality of life in patients with hypertrophic cardiomyopathy in the AFFECT-HCM study.

Assessing the psychometric properties of generic (EQ-5D-5L) and disease-specific (KCCQ) quality of life in patients with hypertrophic cardiomyopathy in the AFFECT-HCM study.

Journal: Open heart

Published: January 06, 2025

Screening for cardiac sarcoidosis: diagnostic approach and long-term follow-up in a tertiary centre.

Screening for cardiac sarcoidosis: diagnostic approach and long-term follow-up in a tertiary centre.

Journal: Netherlands heart journal : monthly journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation

Published: December 06, 2024

Family screening for hypertrophic cardiomyopathy: Initial cardiologic assessment, and long-term follow-up of genotype-positive phenotype-negative individuals.

Family screening for hypertrophic cardiomyopathy: Initial cardiologic assessment, and long-term follow-up of genotype-positive phenotype-negative individuals.

Journal: International journal of cardiology

Published: November 15, 2024

Loss of quality of life and increased societal costs in patients with hypertrophic cardiomyopathy: the AFFECT-HCM study.

Loss of quality of life and increased societal costs in patients with hypertrophic cardiomyopathy: the AFFECT-HCM study.

Journal: European heart journal. Quality of care & clinical outcomes

Published: August 27, 2024

Biatrial arrhythmogenic substrate in patients with hypertrophic obstructive cardiomyopathy.

Biatrial arrhythmogenic substrate in patients with hypertrophic obstructive cardiomyopathy.

Journal: Heart rhythm

Published: November 05, 2023

Biomechanical response of ultrathin slices of hypertrophic cardiomyopathy tissue to myosin modulator mavacamten.

Biomechanical response of ultrathin slices of hypertrophic cardiomyopathy tissue to myosin modulator mavacamten.

Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie

Published: September 20, 2023

Showing 1-12 of 102

Last Updated: 09/26/2026